July 21, 2011 | Filed under: Health,News | Posted by:
An experimental drug that targets one of the underlying processes that may cause Alzheimer’s disease may be safer over the long run than previously thought, researchers say.
Posted by
on July 21, 2011. Filed under Health, News.
You can follow any responses to this entry through the RSS 2.0.
You can skip to the end and leave a response. Pinging is currently not allowed.